Clinically potential subclasses of retinoid synergists revealed by gene expression profiling

Molecular Cancer Therapeutics

Volumn 2, Issue 1, 2003, Pages 49-58

  Ishida, Seiichi ^a   Shigemoto Mogami, Yukari ^a   Kagechika, Hiroyuki ^d   Shudo, Koichi ^c   Ozawa, Shogo ^a   Sawada, Jun Ichi ^b   Ohno, Yasuo ^a   Inoue, Kazuhide ^a  

^a Division of Pharmacology   (Japan)

^b Division of Biochemistry and Immunochemistry   (Japan)

^c NATIONAL INSTITUTE OF HEALTH SCIENCES   (Japan)

^d UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALITRETINOIN; ANTINEOPLASTIC AGENT; RETINOIC ACID; RETINOID;

APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CLASSIFICATION; DNA MICROARRAY; DRUG EFFECT; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC MARKER; HUMAN; METHODOLOGY; STRUCTURE ACTIVITY RELATION;

ANTICARCINOGENIC AGENTS; APOPTOSIS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC MARKERS; HL-60 CELLS; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RETINOIDS; STRUCTURE-ACTIVITY RELATIONSHIP; TRETINOIN;

EID: 0141576586     PISSN: 15357163     EISSN: 15388514     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sporn, M. B., Roberts, A. B., and Goodman, D. S. (eds.). The Retinoids, Ed. 2. New York: Raven Press, 1994.
2. Zhang, J-W., Gu, J., Wang, Z-Y., Chen, S-J., and Chen, Z. Mechanisms of all-trans retinoic acid-induced differentiation of acute promyelocytic leukemia cells. J. Biosci., 25: 275-284, 2000.
3. Tobita, T., Takeshita, A., Kitamura, K., Ohnishi, K., Yanagi, M., Hiraoka, A., Karasuno, T., Takeuchi, M., Miyawaki, S., Ueda, R., Naoe, T., and Ohno, R. Treatment with a new synthetic retinoid, Am80, of acute promyelocytic leukemia relapsed from complete remission induced by all-trans retinoic acid. Blood, 90: 967-973, 1997. (Pubitemid 27314129)
4. Collins, S. J. The HL-60 promyelocytic leukemia cell line: proliferation, differentiation, and cellular oncogene expression. Blood, 70: 1233-1244, 1987. (Pubitemid 18026122)
5. Breitman, T. R., Selonic, S. E., and Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980. (Pubitemid 10049852)
6. Ohta, K., Kawachi, E., Inoue, N., Fukasawa, H., Hashimoto, Y., Itai, A., and Kagechika, H. Retinoidal pyrimidinecarbosylic acids. Unexpected diaza-substituent effects in retinobenzoic acids. Chem. Pharm. Bull. (Tokyo), 48: 1504-1513, 2000.
7. Ebisawa, M., Kawachi, E., Fukasawa, H., Hashimoto, Y., Itai, A., Shudo, K., and Kagechika, K. Novel thiazolidinedione derivatives with retinoid synergistic activity. Biol. Pharm. Bull., 21: 547-549, 1998. (Pubitemid 28259435)
8. Umemiya, H., Fukasawa, H., Ebisawa, M., Eyrolles, L., Kawachi, E., Eisenmann, G., Gronemeyer, H., Hashimoto, Y., Shudo, K., and Kagechika, H. Regulation of retinoidal actions by diazepinylbenzoic acids. Retinoid synergists which activate the RXR-RAR heterodimers. J. Med. Chem., 40: 4222-4234, 1997. (Pubitemid 28042303)
9. Westin, S., Kurokawa, R., Nolte, R. T., Wisely, G. B., McInerney, E. M., Rose, D. W., Milburn, M. V., Rosenfeld, M. G., and Glass, C. K. Interactions controlling the assembly of nuclear-receptor heterodimers and coactivators. Nature (London), 395: 199-202, 1998. (Pubitemid 28425662)
10. Altucci, L., and Gronemeyer, H. The promise of retinoids to fight against cancer. Nat. Rev. Cancer, 1: 181-193, 2001. (Pubitemid 33741893)
11. Nagy, L., Thomazy, V. A., Shipley, G. L., Fesus, L., Lamph, W., Heyman, R. A., Chandraratna, R. A. S., and Davis, P. J. A. Activation of retinoid X receptors induces apoptosis in HL-60 cell lines. Mol. Cell. Biol., 15: 3540-3551, 1995.
12. West, M., Blanchette, C., Dressman, H., Huang, E., Ishida, S., Spang, R., Zuzan, H., Olson, J. A., Jr., Marks, J. R., and Nevins, J. R. Predicting the clinical status of human breast cancer by using gene expression profiles. Proc. Natl. Acad. Sci. USA, 98: 11462-11467, 2001. (Pubitemid 32928751)
13. Alizadeh, A. A., Eisen, M. B., Davis, R. E., Ma, C., Lossos, I. S., Rosenwald, A., Boldrick, J. C., Sabet, H., Tran, T., Yu, X., et al. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling. Nature (Lond.), 403: 503-511, 2000. (Pubitemid 30082188)
14. Kagechika, H., Kawachi, E., Hashimoto, Y., and Shudo, K. Retinobenzoic acid. 2. Structure-activity relationships of chalcone-4-carboxylic acids and flavone-4′-carboxylic acids. J. Med. Chem., 32: 834- 840, 1989.
15. Ebisawa, M., Ohta, K., Kawachi, E., Fukasawa, H., Hashimoto, Y., and Kagechika, H. Novel retinoidal tropolone derivatives. Bioisosteric relationship of tropolone ring with benzoic acid moiety in retinoid structure. Chem. Pharm. Bull. (Tokyo), 49: 501-503, 2001. (Pubitemid 32367691)
16. Swisshelm, K., Ryan, K., Tuchiya, K., and Sager, R. Enhanced expression of an insulin growth factor-like binding protein (mac25) in senescent human mammary epithelial cells and induced expression with retinoic acid. Proc. Natl. Acad. Sci. USA, 92: 4472-4476, 1995.
17. Bertolino, E., Reimund, B., Wildt-Perinic, D., and Clerc, R. G. A novel homeobox protein which recognizes a TGT core and functionally interferes with a retinoid-responsive motif. J. Biol. Chem., 270: 31178-31188, 1995. (Pubitemid 26018397)
18. Reimers, K., Antoine, M., Zapatka, M., Blecken, V., Dickson, C., and Kiefer, P. NoBP, a nuclear fibroblast growth factor 3 binding protein, is cell cycle regulated and promotes cell growth. Mol. Cell. Biol., 21: 4995-5007, 2001.
19. Zhong, S., Salomoni, P., and Pandolfi, P. P. The transcriptional role of PML and the nuclear body. Nat. Cell Biol., 2: E85-E90, 2000.
20. Bloch, D. B., de la Monte, S. M., Guigaouri, P., Filippov, A., and Bloch, K. D. Identification and characterization of a leukocyte-specific component of the nuclear body. J. Biol. Chem., 46: 29198-29204, 1996. (Pubitemid 26382630)
21. Vareli, K., Frangou-Lazaridis, M., van der Kraan, I., and van Driel, R. Nuclear distribution of prothymosin alpha and parathymosin: evidence that prothymosin alpha is associated with RNA synthesis processing and parathymosin with early DNA replication. Exp. Cell Res., 257: 152-161, 2000. (Pubitemid 30324653)
22. Drexler, H. G., Quentmeier, H., MacLeod, R. A., Uphoff, C. C., and Hu, Z. B. Leukemia cell lines: in vitro models for the study of acute promyelocytic leukemia. Leuk. Res., 19: 681-691, 1995.
23. Katagiri, K., Yokoyama, K. K., Yamamoto, T., Omura, S., Irie, S., and Katagiri, T. Lyn and Fgr protein-tyrosine kinase prevent apoptosis during retinoic acid-induced granulocytic differentiation of HL-60 cells. J. Biol. Chem., 271: 11557-11562, 1996. (Pubitemid 26156001)
24. Germain, P., Iyer, J., Zechel, C., and Gronemeyer, H. Co-regulator recruitment and the mechanism of retinoic acid receptor synergy. Nature (Lond.), 415: 187-192, 2002. (Pubitemid 34059522)
25. Takeuchi, M., Yano, T., Omoto, E., Takahashi, K., Kibata, M., Shudo, K., Harada, M., Ueda, R., and Ohno, R. Relapsed acute promyelocytic leukemia previously treated with all- trans retinoic acid: clinical experience with a new synthetic retinoid, Am-80. Leuk. Lymphoma, 31: 444- 451, 1998.
26. Kagechika, K. Therapeutic applications of synthetic retinoids. Drugs, 3: 73-83, 2000. Organization for Pharmaceutical Safety and Research Organization for Pharmaceutical Safety and Research